l carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in
Gut Derived Metabolite, Trimethylamine N oxide (TMAO) in Cardio Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics Trimethylamine Noxide: breathe new life Subramaniam 2018 British Journal of Pharmacology Wiley Online Library Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Meat metabolizing bacteria in atherosclerosis Nature Medicine Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect
Pay in 4 interest-free payments of $6.91 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




